LyfeSci Research & Innovation, a newly established Contract Research Organization (CRO) led by physicians, is officially launching with a clear mission to transform the clinical research landscape. Rooted in a site-first approach and an unwavering focus on patient outcomes, LyfeSci combines robust clinical insight with a human-centered strategy. The organization offers a broad range of research services that extend from pre-clinical development to studies involving real-world data and evidence.
Health Technology Insights: Spring Health Launches VERA-MH for AI Validation in Mental Health
The company is guided by the belief that successful clinical trials begin with a deep understanding of patient and site needs. According to Tapan Parikh, MD, Founder and CEO, the company is determined to reshape the research experience by prioritizing those who are directly impacted—patients and the clinicians who care for them. He emphasized that when CROs design solutions that support clinical sites effectively, it not only speeds up trial timelines but also leads to stronger, more relevant data. Dr. Parikh added that the team’s combined scientific knowledge and use of advanced technology will help bring these goals to life.
LyfeSci is also focused on building strong, efficient partnerships across the research ecosystem. By offering customized solutions, the organization seeks to simplify processes for investigators, minimize operational burdens, and ensure that patients have a smoother experience throughout each phase of the trial. Its core offerings include early-stage research, IND application support, end-to-end clinical trial management, data analysis, safety monitoring, and real-world data evaluation.
Health Technology Insights: Elektra Health and Oscar Launch HelloMeno Menopause Plan
Chief Medical Officer William Gannon Jr., MD, who brings over three decades of experience from both sponsor and CRO roles, stressed the importance of designing trials that are meaningful in actual clinical settings. He noted that the goal is to make studies more accessible to patients and manageable for healthcare providers, while also delivering value to sponsors. Dr. Gannon believes this approach will make a real difference in how new treatments are evaluated and ultimately delivered to the people who need them.
With a leadership team deeply rooted in clinical practice and research operations, LyfeSci aims to bridge the gap between scientific innovation and everyday patient care. The organization is poised to become a trusted partner for sponsors and sites seeking to carry out impactful, high-quality clinical research.
Health Technology Insights: Oshi Health Launches Access+ to Boost GI Practice Growth
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source- businesswire
